Filing Details
- Accession Number:
- 0001179110-13-009248
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-28 17:59:11
- Reporting Period:
- 2013-05-23
- Filing Date:
- 2013-05-28
- Accepted Time:
- 2013-05-28 17:59:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | President, Ceo, Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Disposition | 2013-05-23 | 5,666 | $21.62 | 264,789 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $9.36 | 2006-06-08 | 2015-06-08 | 39,383 | 39,383 | Direct |
| Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 260,000 | 260,000 | Direct |
| Common Stock | Stock Option (right to buy) | $11.27 | 2008-05-30 | 2017-05-30 | 85,000 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 43,333 | 43,333 | Direct |
| Common Stock | Stock Option (right to buy) | $18.63 | 2009-06-15 | 2018-08-13 | 93,750 | 93,750 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-05-28 | 2019-05-28 | 37,000 | 109,800 | Direct |
| Common Stock | Stock Option (right to buy) | $5.86 | 2010-03-31 | 2019-05-28 | 130,500 | 130,500 | Direct |
| Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 105,000 | 105,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 100,000 | 100,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 85,000 | 85,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-06-08 | 39,383 | 39,383 | Direct |
| 2016-06-01 | 260,000 | 260,000 | Direct |
| 2017-05-30 | 85,000 | 85,000 | Direct |
| 2018-05-23 | 43,333 | 43,333 | Direct |
| 2018-08-13 | 93,750 | 93,750 | Direct |
| 2019-05-28 | 37,000 | 109,800 | Direct |
| 2019-05-28 | 130,500 | 130,500 | Direct |
| 2020-06-03 | 105,000 | 105,000 | Direct |
| 2022-05-22 | 100,000 | 100,000 | Direct |
| 2024-05-14 | 85,000 | 85,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable based on the achievement of certain performance milestones.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $21.5900 and $21.6800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
Billionaire Hedge Funds
